350 related articles for article (PubMed ID: 32493812)
1. Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19.
Chen J; Kelley WJ; Goldstein DR
J Immunol; 2020 Jul; 205(2):313-320. PubMed ID: 32493812
[TBL] [Abstract][Full Text] [Related]
2. Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection.
Netea MG; Giamarellos-Bourboulis EJ; Domínguez-Andrés J; Curtis N; van Crevel R; van de Veerdonk FL; Bonten M
Cell; 2020 May; 181(5):969-977. PubMed ID: 32437659
[TBL] [Abstract][Full Text] [Related]
3. Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19.
Chu H; Chan JF; Wang Y; Yuen TT; Chai Y; Hou Y; Shuai H; Yang D; Hu B; Huang X; Zhang X; Cai JP; Zhou J; Yuan S; Kok KH; To KK; Chan IH; Zhang AJ; Sit KY; Au WK; Yuen KY
Clin Infect Dis; 2020 Sep; 71(6):1400-1409. PubMed ID: 32270184
[TBL] [Abstract][Full Text] [Related]
4. Severe COVID-19 and aging: are monocytes the key?
Pence BD
Geroscience; 2020 Aug; 42(4):1051-1061. PubMed ID: 32556942
[TBL] [Abstract][Full Text] [Related]
5. Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS.
Rokni M; Ghasemi V; Tavakoli Z
Rev Med Virol; 2020 May; 30(3):e2107. PubMed ID: 32267987
[TBL] [Abstract][Full Text] [Related]
6. Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19.
Yap JKY; Moriyama M; Iwasaki A
J Immunol; 2020 Jul; 205(2):307-312. PubMed ID: 32493814
[TBL] [Abstract][Full Text] [Related]
7. Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity.
Schijns V; Lavelle EC
Eur J Immunol; 2020 Jul; 50(7):932-938. PubMed ID: 32438473
[TBL] [Abstract][Full Text] [Related]
8. Immunology of COVID-19: Current State of the Science.
Vabret N; Britton GJ; Gruber C; Hegde S; Kim J; Kuksin M; Levantovsky R; Malle L; Moreira A; Park MD; Pia L; Risson E; Saffern M; Salomé B; Esai Selvan M; Spindler MP; Tan J; van der Heide V; Gregory JK; Alexandropoulos K; Bhardwaj N; Brown BD; Greenbaum B; Gümüş ZH; Homann D; Horowitz A; Kamphorst AO; Curotto de Lafaille MA; Mehandru S; Merad M; Samstein RM;
Immunity; 2020 Jun; 52(6):910-941. PubMed ID: 32505227
[TBL] [Abstract][Full Text] [Related]
9. Myocardial injury and COVID-19: Possible mechanisms.
Babapoor-Farrokhran S; Gill D; Walker J; Rasekhi RT; Bozorgnia B; Amanullah A
Life Sci; 2020 Jul; 253():117723. PubMed ID: 32360126
[TBL] [Abstract][Full Text] [Related]
10. Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2 compared with other respiratory viruses.
Mick E; Kamm J; Pisco AO; Ratnasiri K; Babik JM; Castañeda G; DeRisi JL; Detweiler AM; Hao SL; Kangelaris KN; Kumar GR; Li LM; Mann SA; Neff N; Prasad PA; Serpa PH; Shah SJ; Spottiswoode N; Tan M; Calfee CS; Christenson SA; Kistler A; Langelier C
Nat Commun; 2020 Nov; 11(1):5854. PubMed ID: 33203890
[TBL] [Abstract][Full Text] [Related]
11. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection.
Conti P; Younes A
J Biol Regul Homeost Agents; 2020 March-April,; 34(2):339-343. PubMed ID: 32253888
[TBL] [Abstract][Full Text] [Related]
12. Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures.
Eroshenko N; Gill T; Keaveney MK; Church GM; Trevejo JM; Rajaniemi H
Nat Biotechnol; 2020 Jul; 38(7):789-791. PubMed ID: 32504046
[No Abstract] [Full Text] [Related]
13. The Science Underlying COVID-19: Implications for the Cardiovascular System.
Liu PP; Blet A; Smyth D; Li H
Circulation; 2020 Jul; 142(1):68-78. PubMed ID: 32293910
[TBL] [Abstract][Full Text] [Related]
14. Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.
Lin L; Lu L; Cao W; Li T
Emerg Microbes Infect; 2020 Dec; 9(1):727-732. PubMed ID: 32196410
[TBL] [Abstract][Full Text] [Related]
15. COVID-19: The Immune Responses and Clinical Therapy Candidates.
Zhand S; Saghaeian Jazi M; Mohammadi S; Tarighati Rasekhi R; Rostamian G; Kalani MR; Rostamian A; George J; Douglas MW
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32756480
[TBL] [Abstract][Full Text] [Related]
16. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response.
Astuti I; Ysrafil
Diabetes Metab Syndr; 2020; 14(4):407-412. PubMed ID: 32335367
[TBL] [Abstract][Full Text] [Related]
17. Seasonality of Respiratory Viral Infections.
Moriyama M; Hugentobler WJ; Iwasaki A
Annu Rev Virol; 2020 Sep; 7(1):83-101. PubMed ID: 32196426
[TBL] [Abstract][Full Text] [Related]
18. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
Ahmed-Hassan H; Sisson B; Shukla RK; Wijewantha Y; Funderburg NT; Li Z; Hayes D; Demberg T; Liyanage NPM
Front Immunol; 2020; 11():1979. PubMed ID: 32973803
[TBL] [Abstract][Full Text] [Related]
19. A consideration of publication-derived immune-related associations in Coronavirus and related lung damaging diseases.
Geifman N; Whetton AD
J Transl Med; 2020 Aug; 18(1):297. PubMed ID: 32746922
[TBL] [Abstract][Full Text] [Related]
20. The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections.
Zhang YY; Li BR; Ning BT
Front Immunol; 2020; 11():2033. PubMed ID: 32922406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
